m.LearnBecome a PartnerBecome a Partner
m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset
LoginOpen Demat Account
m.Stock by Mirae Asset
LoginOpen Demat Account
Samrat Pharmachem Ltd logo

Samrat Pharmachem Ltd Share Price

Current price unavailable.
As on - | -
PharmaceuticalsSmall Cap
BuySell

Volume Analysis

SPOT Pivot Levels

TypeClassicFibonacci
R1 --
R2--
R3--
PP- -
S1--
S2--
S3 --

Ratios

ParticularsDec 2025Sep 2025Jun 2025Mar 2025Dec 2024
ROCE-4.92-12.92-
ROE-2.22-9.91-
EPS-1.49-1.9-0.74-1.299.01

Peer Comparison

Scrip NamePriceDaily changeM CapPE Ratio1 Year Return
No data available

Corporate Action

April 7, 2026
Certificate u/r 74(5) for the quarter ended March 31 2026
April 7, 2026
Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanySamrat Pharmachem Ltd-
2CIN NO.L24230GJ1992PLC017820
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 0.00
4Highest Credit Rating during the previous FY -
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: Nishant Kankaria
Designation: Company Secretary and Compliance Officer
EmailId: contact@samratpharmachem.in
Name of the Chief Financial Officer: Rajesh Mehta
Designation: CFO
EmailId: rajesh@samratpharmachem.com

Date: 07/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

About Samrat Pharmachem Ltd

Equity img
Samrat Pharmachem Limited was incorporated on June 16, 1992 at Ankleshwar in Gujarat led by the Promoters, Mr. Lalit Mehta & Mr. Rajesh Mehta. Since then, it envisioned to focus on lodine Derivatives as their core products. The Company's principal activities are manufacturing and selling chemicals. Company is a producer of pharmaceutical chemicals. The intermediates produced are used in pharmaceut...
ISIN :INE103E01016

Registered Office

Plot No A2/3445,GIDC Phase IV

Contact number

+ 91-2646-220774

Email

Registrars

Link Intime India Pvt Ltd
C-13 Pannalal Silk Mills Cmpd LBS Marg Bhandup West Mumbai - 400 078

Contact number

+ 91-022-25963838

Email

Management

Lalit Mehta (Chairman)

Lalit Mehta (Director)

FAQs

The share price of Samrat Pharmachem Ltd on the BSE is - as on -

Note : Securities shown above are only for illustrative purposes and not recommendatory in nature. The data represents best/cumulative figures till date.